Anti-Human Initiation Factor 4E Binding Protein 1 (4E-BP1)

Anti-Human Initiation Factor 4E Binding Protein 1 (4E-BP1)

Product No.: I-458

[product_table name="All Top" skus="I-458"]

- -
- -
Target
Initiation Factor 4E Binding Protein 1
Product Type
Polyclonal Antibody
Applications
IHC FFPE
,
WB

- -
- -
Select Product Size

Data

- -
- -

Antibody Details

Product Details

Reactive Species
Human
Host Species
Rabbit
Immunogen
PN:I-459
Product Concentration
0.5 mg/ml
Formulation
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Storage and Handling
This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
Rabbit Anti-Human Initiation Factor 4E Binding Protein 1 (4E-BP1) recognizes Human and Mouse 4E-BP1. This polyclonal antibody was purified using affinity chromatography.
Background
The translation of mRNA in eukaryotic cells is regulated by the presence of amino acids through multiple mechanisms (reviewed in 1). One such mechanism involves the evolutionarily conserved serine/threonine kinase TOR (Target of rapamycin, also known as mTOR), which regulates cell growth and cell cycle through its ability to integrate signals from nutrient levels and growth factors (reviewed in 2). One downstream target of TOR is the eukaryotic initiation factor 4E binding protein 1 (4E-BP1) whose phosphorylation prevents its association with eIF4E, preferentially stimulating translation of mRNAs containing long, highly structured 5’-UTRs.1 Rapamycin inhibits TOR resulting in reduced cell growth and reduced rates of cell cycle and cell proliferation (reviewed in 3), at least in part by inhibiting the activity of TOR towards 4E-BP1.

Antigen Details

References & Citations

1. Shah, OJ. et al. (2000) Am. J. Physiol. Endocrinol. Metab. 279:E715
2. Shamji, AF. et al. (2003) Mol. Cell 12:271
IHC FFPE
General Western Blot Protocol

Certificate of Analysis

Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.